• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AJMC® in the Press, February 19, 2021

Article

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An article by FitchRatings cited an article by The Center for Biosimilars®, a sister site of AJMC.com, the website of The American Journal of Managed Care® (AJMC®). The article, “Biosimilars Bring Value to Health Care,” highlighted that as health care transitions away from fee-for-service–style practice, biosimilars can increase access and decrease costs to play a potentially vital role in value-based care.

A piece by Philstar.com featured an article published in an August 2017 supplement to AJMC®. The article, “Overview of Atopic Dermatitis,” noted that atopic dermatitis is a multifaceted, chronic relapsing inflammatory skin disease that is the most common skin disease in children, affecting approximately 15% to 20% of children and 1% to 3% of adults.

Related Videos
Leslie Fish, PharmD.
Ronesh Sinha, MD
Adam Colborn, JD
Beau Raymond, MD
Judith Alberto, MHA, RPh, BCOP, director of clinical initiatives, Community Oncology Alliance
Yuqian Liu, PharmD
Jenny Craven, PharmaD, BCPS
Kimberly Westrich, MA
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Sarah Bajorek, PhD, BCACP, MBA.
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.